Apotex Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for APOTEX INC, and what generic and branded alternatives to APOTEX INC drugs are available?
APOTEX INC has one hundred and five approved drugs.
There are fourteen tentative approvals on APOTEX INC drugs.
Summary for Apotex Inc
| US Patents: | 0 |
| Tradenames: | 83 |
| Ingredients: | 80 |
| NDAs: | 105 |
| Drug Master File Entries: | 2 |
| Patent Litigation for Apotex Inc: | See patent lawsuits for Apotex Inc |
| PTAB Cases with Apotex Inc as petitioner: | See PTAB cases with Apotex Inc as petitioner |
Drugs and US Patents for Apotex Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apotex Inc | IPRATROPIUM BROMIDE | ipratropium bromide | SOLUTION;INHALATION | 075441-001 | Mar 28, 2001 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Apotex Inc | IBANDRONATE SODIUM | ibandronate sodium | TABLET;ORAL | 078948-001 | Mar 19, 2012 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Apotex Inc | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | candesartan cilexetil; hydrochlorothiazide | TABLET;ORAL | 202884-001 | Dec 4, 2012 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Apotex Inc | MOEXIPRIL HYDROCHLORIDE | moexipril hydrochloride | TABLET;ORAL | 078454-002 | Jun 2, 2008 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Apotex Inc | OLANZAPINE | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 091265-004 | Oct 24, 2011 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Apotex Inc | RASAGILINE MESYLATE | rasagiline mesylate | TABLET;ORAL | 201950-001 | Sep 12, 2013 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
